- Business Wire•8 days ago
PURE Bioscience, Inc. , creator of the patented silver dihydrogen citrate antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the market.
- Capital Cube•16 days ago
Categories: Yahoo Finance Get free summary analysis PURE Bioscience, Inc. reports financial results for the year ended July 31, 2016. We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Ecolab Inc., Ocean Bio-Chem, Inc., United-Guardian, Inc. and Calgon Carbon Corporation (ECL-US, OBCI-US, UG-US and CCC-US) that have also reported for this period. Highlights ... Read more (Read more...)
- Accesswire•17 days ago
SAN DIEGO, CA / ACCESSWIRE / November 21, 2016 / PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC ) antimicrobial, today announced that Hank R. Lambert, CEO ...
PURE : Summary for PURE BIOSCIENCE IN COM NPV - Yahoo Finance
PURE Bioscience, Inc. (PURE)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-3.75|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|